financetom
Business
financetom
/
Business
/
Market Chatter: AppLovin Sees Short Interest Rise, Reversing Decline Seen Earlier in 2025
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: AppLovin Sees Short Interest Rise, Reversing Decline Seen Earlier in 2025
Sep 10, 2025 12:31 PM

03:10 PM EDT, 09/10/2025 (MT Newswires) -- Short interest in AppLovin ( APP ) is rising again, even after traders betting against the ad-tech firm suffered an estimated $3.4 billion in paper losses over the past six months, Bloomberg reported Wednesday.

According to the report, data from S3 Partners showed that shares borrowed and sold short climbed this week to 6.5% of the float, up from 4.7% in early August, representing the highest level since March.

AppLovin's ( APP ) stock has surged more than 75% this year, with the latest rally being driven by the company's upcoming inclusion in the S&P 500 on Sept. 22, the report said.

Analysts caution that much of the positive news is already priced in, with the stock trading at roughly 47 times forward earnings, raising concerns about overvaluation, Bloomberg said.

Shares of AppLovin ( APP ) were up 1.2% in recent trading.

AppLovin ( APP ) did not immediately reply to MT Newswires' request for comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 565.24, Change: +7.07, Percent Change: +1.27

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
AstraZeneca signs up to $555 million AI deal with Algen to develop therapies
AstraZeneca signs up to $555 million AI deal with Algen to develop therapies
Oct 6, 2025
Oct 6 (Reuters) - Algen Biotechnologies said on Monday it had agreed to grant AstraZeneca ( AZN ) a license to develop therapies the U.S.-based biotech discover using its AI-driven gene-editing platform, in a deal worth up to $555 million. AstraZeneca ( AZN ) will get exclusive rights to develop and sell approved therapies, if any, that target immune system-related...
American Rebel Invests $1.5 Million in RAEK Data for Branded Product Expansion
American Rebel Invests $1.5 Million in RAEK Data for Branded Product Expansion
Oct 6, 2025
11:18 AM EDT, 10/06/2025 (MT Newswires) -- American Rebel ( AREB ) said Monday it invested $1.5 million in RAEK Data as part of efforts to expand its branded products and advance its growth initiatives. American Rebel ( AREB ) will leverage RAEK's first-party data engine designed for the artificial intelligence economy to drive targeted customer acquisition and retention in...
GreenFirst Forest Products to Resume Operations at Mills
GreenFirst Forest Products to Resume Operations at Mills
Oct 6, 2025
11:19 AM EDT, 10/06/2025 (MT Newswires) -- GreenFirst Forest Products ( ICLTF ) , which last week said it was curtailing saw mill operations at some operations, Monday said it is preparing to resume operations at its Kapuskasing, Hearst and Cochrane mills this week. The decision change was prompted by reports that the Federal and Ontario governments have reached funding...
Blink Charging Stock Pops On UK Deal To Build 700 EV Chargers
Blink Charging Stock Pops On UK Deal To Build 700 EV Chargers
Oct 6, 2025
Blink Charging Co. ( BLNK ) shares are trading higher on Monday after the company disclosed that it has been chosen by The West Yorkshire Combined Authority (WYCA) to partner on a £1.41 million ($1.9 million) initiative aimed at rolling out the first phase of a regional electric vehicle (EV) charging network. The 15-year agreements is signed with all five...
Copyright 2023-2026 - www.financetom.com All Rights Reserved